Oral Vitamin B12 Supplementation
Recommended Dosing
For vitamin B12 deficiency, oral supplementation with 1000-2000 mcg daily is as effective as intramuscular injections for most patients, including those with malabsorption disorders like pernicious anemia. 1, 2, 3
Standard Treatment Protocol
Initial Treatment Phase:
- 1000-2000 mcg oral cyanocobalamin daily for the first month to rapidly correct deficiency 1, 4, 2
- This high dose ensures adequate absorption even in patients with impaired intrinsic factor or gastric acid production 3, 5
Maintenance Dosing:
- Dietary insufficiency only: 125-250 mcg daily after initial correction 4
- Malabsorption conditions (pernicious anemia, atrophic gastritis, post-bariatric surgery): 1000 mcg daily indefinitely 1, 4, 2
- Post-bariatric surgery specifically: 1000 mcg daily oral OR 1000 mcg monthly intramuscular 1, 6
Special Population Considerations
Elderly Patients (>75 years):
- Higher risk population with 18.1% of those >80 years having metabolic B12 deficiency 1, 6
- Oral supplementation 1000-2000 mcg daily is effective despite age-related atrophic gastritis affecting up to 20% of older adults 1, 7
- Absorption of crystalline vitamin B12 remains intact even with atrophic gastritis 7
Gastrointestinal Disorders:
- Ileal resection >20 cm: 1000 mcg intramuscular monthly for life (oral may be insufficient) 1, 6, 7
- Ileal resection <20 cm: Typically does not cause deficiency 6, 7
- Crohn's disease with ileal involvement >30-60 cm: Annual screening and prophylactic supplementation with 1000-2000 mcg oral daily OR 1000 mcg intramuscular monthly 1, 6
- Post-bariatric surgery (Roux-en-Y, biliopancreatic diversion): 1000-2000 mcg daily sublingual OR 1000 mcg monthly intramuscular 6
When Intramuscular Administration is Preferred
Absolute indications for intramuscular therapy:
- Neurological involvement (paresthesias, neuropathy, cognitive impairment, gait disturbances): Hydroxocobalamin 1000 mcg intramuscular on alternate days until symptoms improve, then 1000 mcg every 2 months for life 1, 6
- Severe deficiency with neurological symptoms: More rapid improvement with intramuscular route 2, 8
- Swallowing difficulties or compliance concerns 3
Without neurological involvement:
- Hydroxocobalamin 1000 mcg intramuscular three times weekly for 2 weeks, then maintenance of 1000 mcg every 2-3 months for life 1, 6
- Monthly dosing (1000 mcg intramuscular monthly) is more effective than 3-monthly injections and may be necessary for some patients to meet metabolic requirements 1, 6
Treatment Duration
Lifelong supplementation is required for:
- Pernicious anemia 4, 8
- Ileal resection >20 cm 1, 6
- Post-bariatric surgery 1, 6, 2
- Atrophic gastritis 4
- Chronic PPI use >12 months 7, 2
- Metformin use >4 months 1, 7
Treatment should continue until the underlying cause is corrected, or indefinitely if the cause cannot be reversed 1
Monitoring Protocol
Initial monitoring:
- Recheck serum B12 at 3 months after starting supplementation 6
- Second recheck at 6 months 6
- Third recheck at 12 months to ensure stabilization 6
Long-term monitoring:
- Annual monitoring once levels stabilize 1, 6
- Target homocysteine <10 μmol/L for optimal cardiovascular outcomes 1, 6
- Monitor for resolution of neurological symptoms, which is more important than laboratory values in patients with neurological involvement 6
Critical Formulation Considerations
Preferred forms:
- Methylcobalamin or hydroxocobalamin should be used instead of cyanocobalamin in patients with renal dysfunction, as cyanocobalamin requires renal clearance and is associated with increased cardiovascular events (hazard ratio 2.0) 1, 6
- For most other patients, cyanocobalamin is acceptable and widely available 9, 5
Essential Cautions
Never administer folic acid before treating B12 deficiency - this can mask the anemia while allowing irreversible neurological damage (subacute combined degeneration of the spinal cord) to progress 1, 6, 7, 8
Do not discontinue supplementation even if levels normalize - patients with malabsorption require lifelong therapy and will relapse if treatment is stopped 6, 8
Up to 50% of patients may require individualized injection regimens with more frequent administration (ranging from twice weekly to every 2-4 weeks) to remain symptom-free, particularly those with neurological involvement 8